Alexej Dick

Background

About Alexej Dick

Solving exciting challenges for unmet medical needs with exceptional teams, from CNS and infectious disease drug discovery to business performance analytics, turning scientific and commercial data into scalable decisions that move outcomes-Drug Discovery & Translational R&D leader with 10+ years advancing mechanism-based therapeutics across CNS oncology (brain metastasis) and infectious disease from target assessment through in vivo efficacy and translational framing. Integrating CADD/AIDD, SBDD/LBDD, molecular modeling, structural biology, quantitative biophysics, and MOA studies to convert complex datasets into decision-grade hypotheses, prioritized designs, and executable development plans.Cross-functional operator bridging medicinal chemistry, protein science/antibody engineering, assay biology, in vivo pharmacology, bioanalysis, and data science, building DBTL cadences, milestone-based governance, and multi-CRO/CMO partnerships across hit finding, lead optimization, MPO, ADME/DMPK, PK/PD, and CNS exposure.Experience supporting GLP/GMP-aligned practices, fit-for-purpose validation, assay/method transfer, audit readiness, and structured data capture.Complementary business and analytics capability across program/portfolio management, budgeting, partner/account management, KPI/OKR design, and data-driven decision support. Continuous improvement mindset grounded in Lean Six Sigma, statistical process control, process capability analysis, root cause analysis, and risk management.